In this episode, Thomas Fuchs, Chief AI Officer at Eli Lilly, shares his journey from early machine learning research to spearheading transformative AI initiatives across the pharmaceutical value chain. Lilly is running over a thousand AI projects—from drug discovery and development to manufacturing and commercial operations—leveraging innovations like language models for chatbots, computer vision for quality control, and biomarker development.

Thomas emphasizes trust, transparency, and collaboration as critical to AI adoption, supported by AI certification programs for all Lilly technology employees, as well as AI education resources being made available for everyone at Lilly. He also highlights the company’s unique “lab-in-the-loop” setups that generate synthetic data to accelerate innovation.

Thomas shares real-world successes, including AI-assisted drug discovery and intelligent chatbots, and how AI is building confidence across the organization. With robust data infrastructure and scalable strategies for synthesizing large datasets, Lilly is driving rapid innovation. Thomas predicts faster drug design, broader access to medicines, and continuous education as defining trends for AI in healthcare. Take a listen.

Thomas Fuchs, Chief AI Officer, Eli Lilly and Company

Stay up to date on current trends in healthcare's digital transformation. Featuring C-suite executives from the healthcare and technology sectors, podcast hosts Rohit Mahajan and Ritu M. Uberoy discuss how they are driving digital health innovation and leveraging emerging technologies to create the healthcare experiences of the future.

About the hosts:

Rohit Mahajan, Managing Partner and CEO, Damo and BigRio: Rohit is an entrepreneur and a leader in the information technology and software industry. His focus lies in the field of artificial intelligence and digital transformation for healthcare clients. His recently published full length book,  Quantum Care, A Deep Dive into AI for Health Delivery and Research has been trending #1 in several categories on Amazon. Rohit is a Wharton School Fellow and a graduate from the Harvard Business School. You can follow and connect with him on https://www.linkedin.com/in/rmahaj/

Ritu M. Uberoy, Managing Partner at Damo and BigRio has over twenty-five years of experience in the software and information technology industry in the United States and in India. She established Saviance Technologies in India and has been involved in the delivery of several successful software projects and products to clients in various industry segments.
You can follow and connect with her on https://www.linkedin.com/in/ritu-m-uberoy/

To receive alerts on new episodes, please subscribe to The Healthcare Digital Transformation Leader newsletter. Link is provided below.

Thomas Fuchs, Chief AI Officer, Eli Lilly and Company

The Big Unlock